pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
ERAS-4001
Solid Tumor
$ERAS
Erasca, Inc.
0
catalysts
Phase 2
ERC-1671
Gliovac
Gliosarcoma
ERC Belgium SA
0
catalysts
ERGOCALCIFEROL CAPSULES,
ERGOCALCIFEROL CAPSULES, (ERGOCALCIFEROL CAPSULES,)
PURACAP PHARM LLC
0
catalysts
ERGOMAR SUBLINGUAL
ERGOMAR SUBLINGUAL (ERGOTAMINE TARTRATE)
PANGEA
← prev
page 82 of 231
next →
131
Pain
89
Neurology
1
0
catalysts
ERLOTINIB
ERLOTINIB (ERLOTINIB)
EUGIA PHARMA
0
catalysts
Preclinical
ERNA-101
Ovarian Cancer
$ERNA
Ernexa Therapeutics Inc.
0
catalysts
Phase 1
ERSM-5404
Colorectal Cancer
Hibercell Inc
0
catalysts
ERTAPENEM
ERTAPENEM (ERTAPENEM)
EUGIA PHARMA
0
catalysts
ERY
ERY (ERYTHROMYCIN)
PADAGIS US
0
catalysts
ERYTHROMYCIN ETHYLSUCCINATE
ERYTHROMYCIN ETHYLSUCCINATE (ERYTHROMYCIN ETHYLSUCCINATE)
CADILA PHARMS LTD
0
catalysts
ERYTHROMYCIN LACTOBIONATE
ERYTHROMYCIN LACTOBIONATE (ERYTHROMYCIN LACTOBIONATE)
GLAND
0
catalysts
ESCITALOPRAM
ESCITALOPRAM (ESCITALOPRAM)
ALMATICA
0
catalysts
ESMOLOL HYDROCHLORIDE IN SODIUM CHLORIDE
ESMOLOL HYDROCHLORIDE IN SODIUM CHLORIDE (ESMOLOL HYDROCHLORIDE IN SODIUM CHLORIDE)
MYLAN LABS LTD
0
catalysts
ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES, 20 MG
ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES, 20 MG (ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES, 20 MG)
MARKSANS PHARMA
0
catalysts
ESOMEPRAZOLE STRONTIUM
ESOMEPRAZOLE STRONTIUM (ESOMEPRAZOLE STRONTIUM)
BELCHER
0
catalysts
Preclinical
ESP-2001
Primary Sclerosing Cholangitis
$ESPR
Esperion Therapeutics, Inc.
0
catalysts
Preclinical
ET-101
Amyotrophic Lateral Sclerosis
Eikonoklastes Therapeutics Inc
0
catalysts
Phase 2
ET-1402
Hepatocellular Carcinoma
Eureka Therapeutics Inc
0
catalysts
Phase 2
ETD-001
Cystic Fibrosis
Enterprise Therapeutics Ltd
0
catalysts
Preclinical
ETH-42
Primary Ciliary Dyskinesia
ethris GmbH
0
catalysts
ETONOGESTREL AND ETHINYL ESTRADIOL VAGINAL RING
ETONOGESTREL AND ETHINYL ESTRADIOL VAGINAL RING (ETONOGESTREL AND ETHINYL ESTRADIOL VAGINAL RING)
XIROMED
0
catalysts
Phase 2
ETX-101
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
Encoded Therapeutics Inc
0
catalysts
Phase 2
ETX-19477
Ovarian Cancer
858 Therapeutics Inc
0
catalysts
Phase 2
ETX-636
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
ENSEM Therapeutics Inc
0
catalysts
Phase 2
EU-101
Colorectal Cancer
Eutilex Co Ltd
0
catalysts
Phase 1
EV68-228-N
Flaccid Paralysis
KBio Inc
0
catalysts
Phase 2
EVM-14
Esophageal Squamous Cell Carcinoma (ESCC)
Everest Medicines Ltd
0
catalysts
Phase 2
EVO-756
Chronic Inducible Urticaria
$EVMN
Evommune, Inc.
0
catalysts
Phase 1
EVOLVE-104
Anal Cancer
EvolveImmune Therapeutics Inc
0
catalysts
Preclinical
EVQ-218
Aspergillosis
Evoq Nano Inc
0
catalysts
